Medicago, Inc. Receives Authorization From Health Canada and Commences Phase II Clinical Trial for an H5N1 Vaccine
6/11/2013 8:48:57 AM
More...
|
Health Canada Expands Indications of Abilify® (aripiprazole), to be the First Add-On Treatment for Major Depressive Disorder (MDD)
6/6/2013 10:15:18 AM
More...
|
AxoGen, Inc. (LECT) Announces Health Canada Approval for AxoGuard® Nerve Connector and AxoGuard® Nerve Protector
6/4/2013 9:39:20 AM
More...
|
StemCells Inc. (STEM)'s Spinal Cord Injury Trial Approved by Health Canada
6/3/2013 9:04:20 AM
More...
|
Janssen Inc. Release: Health Canada Expands Indication for ZYTIGA® in Men With Metastatic Prostate Cancer
5/29/2013 10:12:19 AM
More...
|
Health Canada: Three Companies Recall Antipsychotic Drug Quetiapine
5/20/2013 7:40:52 AM
More...
|
NeuroSigma, Inc. Receives Health Canada Approval for Its Monarch eTNS System
5/2/2013 7:45:45 AM
More...
|
Roche (RHHBY) Release: Health Canada Approves PERJETA™, a New First-In-Class Targeted Therapy for the Treatment of HER2-Positive Metastatic Breast Cancer(1)
4/23/2013 10:42:39 AM
More...
|
Aerocrine's NIOX MINO® Device for Measuring FeNO Receives Approval by Health Canada
4/16/2013 11:00:20 AM
More...
|
Procognia Limited Wins Health Canada Deal
4/15/2013 9:48:50 AM
More...
|
|